Key result
Left ventricular hypertrophy defined by EMINCA criteria had an 8.3% prevalence and was significantly associated with cardiovascular death (HR 1.55; 95% CI 1.19-2.01; P<0.001).
Why the study?
International guideline echocardiographic criteria for LVH are derived from White populations and may be less accurate for other ethnic groups, making ethnically specific evaluation important.
Does the use of ethnically specific echocardiographic criteria (EMINCA) compared to international guidelines alter the estimated prevalence and prognostic implications of left ventricular hypertrophy in a Chinese population?
Cohort (n=20,210)
Yes
Does the use of ethnically specific echocardiographic criteria (EMINCA) compared to international guidelines alter the estimated prevalence and prognostic implications of left ventricular hypertrophy in a Chinese population?
Hazard Ratio: 1.55 (95% CI 1.19–2.01)
p-value: p=<0.001
The prevalence of LVH in a Chinese population varies significantly depending on the echocardiographic criteria used, though both criteria independently predict cardiovascular death.
Ethnic criteria yield lower LVH prevalence without loss of prognostic signal; leaves open whether EMINCA refines risk stratification in Chinese adults.
Background Echocardiographic criteria of left ventricular hypertrophy (LVH) recommended in the international guidelines are derived from a White population, which could be less accurate in estimating LVH burden in other ethnic groups. Given that LVH is an important prognostic factor, assessing its burden using ethnically specific criteria has important implications. We sought to evaluate the prevalence and prognostic implications of LVH based on the EMINCA (Echocardiographic Measurements in Normal Chinese Adults) study criteria and the international guidelines. Methods and Results Nationally representative populations aged ≥35 years (n=20 210; mean age, 56.0 years; 53.3% women) were enrolled from the China Hypertension Survey 2012 to 2015. The EMINCA study criteria for LVH were left ventricular mass index >109 g/m 2 for men and >105 g/m 2 for women; and the international guidelines criteria were left ventricular mass index >115 g/m 2 for men and >95 g/m 2 for women. Prevalence of LVH defined by the EMINCA study and international guidelines was 8.3% (≈56.8 million) and 11.7% (≈80.1 million), respectively. LVH defined by the EMINCA study was associated with adjusted hazard ratio (HR) of 1.55 (95% CI, 1.19–2.01; P <0.001) for cardiovascular death and 1.14 (95% CI, 0.95–1.37; P =0.16) for all‐cause death. LVH defined by the international guidelines was associated with adjusted HR of 1.31 (95% CI, 1.00–1.72; P =0.047) for cardiovascular death and 1.12 (95% CI, 0.94–1.34; P =0.22) for all‐cause death. Conclusions LVH diagnosis based on both criteria was independently associated with cardiovascular death. However, the prevalence of LVH in a general Chinese population varies significantly by the echocardiographic criteria.
No takes yet. Share an insight, caveat, or question.
Cai et al. (2025) conducted a cohort in Left ventricular hypertrophy (n=20,210). Left ventricular hypertrophy (EMINCA criteria) vs. No left ventricular hypertrophy was evaluated on Cardiovascular death (HR 1.55, 95% CI 1.19-2.01, p=<0.001). Left ventricular hypertrophy defined by EMINCA criteria had an 8.3% prevalence and was significantly associated with cardiovascular death (HR 1.55; 95% CI 1.19-2.01; P<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: